NCT03260595 A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03260023 Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03258502 A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection Status COMPLETED Phase PHASE2
NCT03258398 A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer Status COMPLETED Phase PHASE2
NCT03258008 Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer Status TERMINATED Phase PHASE2
NCT03250039 Absorption, Metabolism, Excretion and Absolute Bioavailability Status COMPLETED Phase PHASE1
NCT03248882 Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) Status COMPLETED Phase PHASE2
NCT03248141 Understanding Hemophilia A and B Drug Dosage Administration Patterns Status TERMINATED Phase N/A
NCT03237273 HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound Status UNKNOWN Phase NA
NCT03236493 Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03236051 Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study Status UNKNOWN Phase NA
NCT03235479 Safety and Efficacy Study in Adult Subjects With Acute Migraines Status COMPLETED Phase PHASE3
NCT03233529 Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03232905 Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03230383 A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects Status COMPLETED Phase PHASE1
NCT03220230 Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients. Status COMPLETED Phase N/A
NCT03220191 Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of Palbociclib Status COMPLETED Phase PHASE1